As of 2025-07-12, the Fair Value of Praxis Precision Medicines Inc (PRAX) is -52.18 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 50.54 USD, the upside of Praxis Precision Medicines Inc is -203.24%.
With the market price of 50.54 USD and our fair value calculation, Praxis Precision Medicines Inc (PRAX) is not a good investment. Investing in PRAX stocks now will result in a potential loss of 203.24%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -61.82 | -167.06 | -214.03 | -123.28 | -182.82 | -149.80 |
| YoY growth | -74.09% | -170.24% | -28.12% | 42.40% | -48.30% | -55.67% |
| Market Cap (mil) | 1,029.50 |
| P/E | |
| Forward P/E |
| EPS | -10.44 |
| Avg earnings growth rate | -55.67% |
| TTM earnings | -212.56 |